Dr. Green's Professional Accomplishments

Dr. Green’s Professional Accomplishments Page Two

Dr. Green’s Professional Accomplishments Continued

CLINICAL TRIALS/RESEARCH EXPERIENC

2011—Present

Neothetics: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects. LIPO-202-CL-18

Kythera Biopharmaceuticals: CONTOUR: condition of submental fullness and treatment outcomes registry.

Ulthera: CRUISE: Cellfina registry under investigation for safety and efficacy. ULT-500

Ulthera: Retrospective evaluation of safety of combination treatment with the Ulthera System and Xeomin, Belotero Balance, and Radiesse. ULT-144

Evolus: a multicenter open label, multiple dose, phase II trial to demonstrate the safety of DWP-450 in adult subjects for treatment of moderate to severe glabellar lines. EVOLUS CLIN006

Revance: a phase 2 open label, multicenter study to evaluate the safety and efficacy of RT001 topical gel for the treatment of moderate to severe lateral canthal lines in adults. RT001-CL042

Neothetics: LIPO-202-CL-22: an open label study to evaluate retreatment with LIPO 202

Revance: a phase 2 randomized double blind parallel-group placebo controlled multicenter study to evaluate the efficacy and safety of rt001 topical gel for the treatment of moderate to severe lateral canthal lines in adults RT001-CL041

Evolus: A multi center open label multiple dose phase 2 trial to demonstrate the safety of DWP-450 in adult subjects for treatment of moderate to severe glabellar lines EVOLUS CLIN004

Kythera Submental fat: ATX-101-13-27 Refine 1 & 2. Multicenter, randomized, double-blind, placebo-controlled safety study of ATX-101 (sodium deoxycholate injection) for the reduction of localized subcutaneous fat in the submental area in subjects with clinician-reported submental fat rating scale (CR-SMFRS) grade 1 or CR-SMFRS grade 4.

Zydus Cadila/Cliantha: a randomized, double blind, multicentric, parallel group, active and placebo controlled, three arm clinical study to compare the efficacy and safety of clindamycin phosphate 1.2% / Benzoyl peroxide 5% gel (of Cadila Healthcare Limited, India) versus DUAC gel 9of Stiefel Laboratories, USA) versus Placebo (vehicle Gel) in the ratio of 2:2:1 respectively, in patients with acne vulgaris.

Ulthera: ULT-137: Evaluation of the Safety and Efficacy of the Ulthera System for Wrinkle Reduction. Principal Investigator.

Revance: A phase 3 randomized double-blind parallel-group placebo-controlled multicenter study to evaluate the efficacy and safety of RT001 topical gel for the treatment of moderate to severe lateral canthal lines in adults (Radiant).

Kythera Submental fat: Protocol Number ATX-101-13-27, entitled “A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects with Clinician-Reported Submental Fat Rating Scale (CR SMFRS) Grade 1 or CR-SMFRS Grade 4.

Fibrocell: An open-label single center exploratory study to evaluate Azficel-T (LaViv) for improvement in appearance of fine perioral lines.

Allergan: Bimatoprost (Latisse) for the treatment of eyelash hypotrichosis

Cabochon: Data Monitoring Safety Board for Cabochon Aesthetics’ Marquise System for improvement in the appearance of cellulite.

Kythera Neck: ATX-101-11-23 Refine 1 & 2. Multicenter, randomized, double-blind, placebo-controlled study of ATX-101 (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area using magnetic resonance imaging and a battery of clinician- and subject-reported measurements..

Medicis Restylane Lip: MA-1700-04 A randomized, evaluator-blinded, no-treatment control study of the effectiveness and safety of small particle hyaluronic acid plus lidocaine (SPHAL) in the augmentation of soft tissue fullness of the lips.

Medicis Perlane Mid-Face: MA-1400-05 A randomized, evaluator-blinded, no-treatment-controlled study of the effectiveness and safety of Perlane-L in the correction of midface volume deficit and/or midface contour deficiency.

Palomar Medical: Palomar Icon Skintel Validation. Beta testing of company’s proprietary melanin-measuring technology to determine appropriate intense pulsed light settings..

Allergan: A multicenter, double blind, placebo controlled study assessing patient satisfaction with Latisse® (Bimatoprost Ophthalmic Solution 0.03%) for increasing eyelash prominence..

Noven Pharmaceuticals: A randomized, double blind, parallel group, multicenter, placebo controlled study of the safety and efficacy of HTU-520 in the treatment of mild to moderate distal subungual onychomycosis of the toenails..

2010 – 2011

SkinCare Physicians, Chestnut Hill, MA. Sub-investigator:
Cabochon: Pilot study of Cabochon Aesthetics’ Marquise System for improvement in the appearance of cellulite, CP-01-1003. Trial end date: 12/10.

Zeltiq Abdomen: Non-invasive reduction of abdominal fat utilizing the Juno applicator, ZA10-001. Trial end date: 10/10.

Kythera Neck: Multicenter, randomized, double-blind, placebo-controlled study of ATX-101 (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area using magnetic resonance imaging and a battery of clinician- and subject-reported measurements, ATX-101-09-15.Trial end date: 11/10.

732 Reloxin: A Phase 3, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin in the Treatment of Glabellar Lines. Trial end date: 12/10.

Allergan: JULIDO-002 Juvederm Ultra XL injectable gel for lip augmentation. Trial end date: 08/11.

Medicis: A Phase IV, open label study evaluating the use of Solodyn, Ziana, and Triaz foaming clothes as combination acne therapy as an alternative to treatment with isotretinoin. Trial end date: 11/11.

Allergan: Multicenter double blind randomized placebo-controlled parallel group study to evaluate the safety and efficacy of Botox purified neurotoxin in patients with facial rhytides, crow’s feet lines and glabellar lines. Trial end date: 08/11.

Sound Surgical Technologies: Protocol to evaluate patient measurements after ultrasonic treatment of back fat.

Palomar Medical: Pilot study of laser treatment of actinic keratosis. Trial duration: 3 months.

Cynosure: Protocol CYN09-PICO-II Clinical evaluation of picolase 755nm alexandrite laser for treatment of unwanted tattoos. Start date: 2/23/11.

Kythera: 5-year extension of ATX-101-08-12. Long-term follow-up study of subjects who completed Kythera-sponsored trials of ATX-101 (sodium deoxycholate injections) for the reduction of localized subcutaneous fat in the submental area.

Bella Contour: BELLA01 pilot study to confirm logistics of United States pivotal Bella Contour study. Start date: 2/15/11.

2005

University of Miami Microsurgical Training Center, Miami, FL
Completed 22-hour vascular surgery course supervised by neurological surgeon Dr. Edir Siquera.

2001 – 2002

UHZ Sports Medicine Institute, University of Miami, FL
Full-time research fellow performing clinical outcome studies.

1997 – 1998

Miami Project to Cure Paralysis, Miami, FL
Summer research assistant to Drs. Alexander Marcillo and John Bethea. Examined various neuro-protective agents utilizing a mouse spinal cord injury model.

COMMUNITY/EXTRACURRICULAR

2007—Present

Skin Cancer Screening Volunteer, Miami,FL, Key West, FL
Sylvester Cancer Center Deerfield, Women’s Dermatologic Society, Florida Keys Health Fair, Sunsmart Sprint 5K for Melanoma Awareness (bronze medalist in age group 2008, 2009, and 2010).

2000 – Present

Project Medishare for Haiti, Miami, FL and Haiti
Five trips to Port au Prince and the central plateau on medical missions with University of Miami medical students and physicians. Involved in post-January 2010 earthquake fundraising and medical relief efforts. All aspects of care especially tropical dermatology.

2004 – Present

Princeton Clubs of South Florida/New England, Miami, FL, Boston, MA
Alumni interviewer for area high school student applicants.

2007 – 2010

Camillus House, Miami, FL
Volunteer at homeless shelter staffing Dermatology clinic.

2004 – 2006

University of Miami Clinical Skills Educator, Miami, FL
Certified trainer for 1st/2nd year medical students in physical exam.

2002 – 2004

Northwestern University Student Senate, Chicago, IL
Twice elected Student Senator by Class of 2006. Organized fundraisers, class events, and attended monthly meetings with deans. Elected to Executive Board by Student Senate, Student Organizations Chairman. Allocated funds to 30 student groups.

Loyal Davis Surgical Society, Chicago, IL
Co-President. Organized presentations by Northwestern faculty.

Ashland Clinic, Northwestern, Chicago, IL
Clinic translator for underserved Spanish-speaking population.

1997 – 2001

YWCA English as a Second Language Program, Princeton, NJ
Tutored Latin American immigrants in conversational English.

Princeton University Varsity Sprint Football, Princeton, NJ
2000 Captain of 40-person team. 4-year Letter winner.

Tiger Inn Eating Club, Princeton, NJ
Founded English as a Second Language program to tutor University dining hall staff. Efforts featured in front page Daily Princetonian article. Elected Officer, member Princeton Inter-Club Council for 150-member club.

GOOD CLINICAL PRACTICE TRAINING

10/26/2010 – Dermatology Research Institute SOP 5000 based on National Institute of Health (NIH) Clinical Research Training and educational standard issue by the NIH for conducting clinical research.

07/28/2011 – NIH web-based training course “Protecting Human Research Participants.” Certification Number: 722087

01/20/2014 – NIH web-based training course “Protecting Human Research Participants.” Certification Number: 1364583

< Dr. Green’s Professional Accomplishments Page One

Go to Top